This inventor holds 2 USPTO granted patents. Top assignees: The University of New Mexico, University of Florida Research Foundation Inc.. Active years: 2014-2022.
Company Filing History:
1 out of 942 
1 out of 3,043 
Years Active: 2014-2022
Title: Elizabeth Williamson: Innovator in Cancer Therapeutics
Introduction
Elizabeth Williamson is a prominent inventor based in Gainesville, FL (US). She has made significant contributions to the field of cancer therapeutics, holding 2 patents that focus on innovative methods for treating various types of cancer. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Williamson's latest patents include the use of miR-223-3p as a cancer therapeutic and a method for treating cancer using the same. This invention provides a pharmaceutical composition comprising an inhibitory RNA (iRNA) that mediates sequence-specific degradation of the mRNA encoding Poly (ADP-ribose) polymerase 1 (PARP1). The methods outlined in this patent aim to treat cancers, particularly those with mutations in the BRCA1 and/or BRCA2 genes, including breast cancer, ovarian cancer, prostate cancer, pancreatic cancer, and mesothelioma.
Another notable patent involves bifunctional metnase/intnase inhibitors and related compositions for cancer treatment. This invention focuses on small chemical bifunctional inhibitors of DNA replication and repair proteins Metnase and/or Intnase. These inhibitors are designed to damage DNA and enhance the effectiveness of cancer treatment protocols, including radiation therapy. The methods can be administered as a monotherapy or in combination with other anti-cancer agents.
Career Highlights
Throughout her career, Elizabeth Williamson has worked with esteemed institutions such as the University of New Mexico and the University of Florida Research Foundation Inc. Her research has significantly impacted the field of oncology, particularly in developing novel therapeutic strategies for cancer treatment.
Collaborations
Williamson has collaborated with notable colleagues, including Robert A Hromas and Justin Wray. These partnerships have furthered her research and contributed to the advancement of cancer therapies.
Conclusion
Elizabeth Williamson is a trailblazer in the field of cancer therapeutics, with her innovative patents paving the way for new treatment options. Her dedication to research and collaboration continues to inspire advancements in medical science.